Generic Version

Type: Keyphrase
Name: Generic Version
First reported 44 mins ago - Updated 44 mins ago - 1 reports

Actavis plc confirms generic Diclegis patent challenge

9:25pm BSTActavis plc:Confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-release tablets, 10 mg/10 ... [Published Reuters UK - 44 mins ago]
First reported Jul 10 2014 - Updated 19 hours ago - 1 reports

Insurers balk at pricey generic version of ancient GSK heart drug

The heart drug digoxin--a generic version of GlaxoSmithKline's ($GSK) Lanoxin--used to cost just pennies a pill, making it a prescription that insurance companies were more than happy to cover. Not anymore. The three companies that make generic digoxin ... [Published FiercePharma - Jul 10 2014]
First reported Jul 09 2014 - Updated Jul 10 2014 - 2 reports

EU fines French drug maker Servier

The EU has hit French drugs giant Servier with a huge 331 million euro ($A496.48 million) fine for colluding to delay a cheaper generic version of perindopril, a popular blood pressure treatment.In a statement, the European Commission said total fines ... [Published Trading Room - Jul 09 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Indian stock market and companies daily report (July 10, 2014, Thursday)

ets are expected to open on a flat note with positive bias tracking marginally positive opening on SGX Nifty while most of the Asian markets are trading mixed.The US markets mostly higher over the course of the trading day on Wednesday, partly offsetting ... [Published Stock Markets Review - Jul 10 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Psychiatric drugs associated with 90,000 ER visits yearly, says study

A new study in JAMA Psychiatry  estimates that the adverse effects of psychiatric drugs are related to nearly 90,000 visits to the emergency room each year.The study says those "adverse effects" include everything from allergic reactions to accidental ... [Published SCPR - Jul 10 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Sandoz Launches Generic Diovan in the U.S.

Sandoz announced the U.S. introduction of an authorized generic version of Diovan (valsartan) tablets for the treatment of high blood pressure (HBP).This launch follows the Sandoz U.S. introduction of an authorized generic version of Diovan HCT (valsartan ... [Published Drug Discovery and Development - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Acorda fights Actavis on generic of its multiple sclerosis drug Ampyra

Ireland-headquartered generics major Actavis (NYSE: ACT) has confirmed filing an Abbreviated New Drug Application with the US Food and Drug Administration for dalfampridine, as announced last month .This seeks approval for the company to market dalfampridine ... [Published Pharma Letter - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Mylan launches telmisartan tablets in US market

Mylan Inc., a global pharmaceutical company, has launched telmisartan tablets USP, 20 mg, 40 mg and 80 mg, the generic version of Boehringer Ingelheim's Micardis tablets.Mylan received final approval from the US Food and Drug Administration (FDA) for ... [Published PharmaBiz - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

TEVA PHARMACEUTICAL : EU Fines Servier, Generic Drug-Makers EUR427.7 Million for Violating Antitrust Rules

By Tom FairlessBRUSSELS--European Union antitrust regulators handed down fines totaling 427.7 million euros ($581.8 million) to French pharmaceutical company Servier and five generic drug producers, including Israel's Teva on Wednesday for colluding to ... [Published 4 Traders - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

AFP - EU-France-Israel-antitrust-pharma

EU-France-Israel-antitrust-pharmaContributed by NAMPA / AFP.URGENT EU hits French drugmaker Servier with huge fine over genericsBRUSSELS, July 09, 2014 (AFP) - The EU on Wednesday hit French drugs giant Servier with a huge 331 million euro fine for ... [Published Namibia Press Agency - Jul 09 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 2 reports

Glenmark's telmisartan tablets receives US FDA approval

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics Limited, has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for telmisartan tablets. Glenmark will commence distribution ... [Published PharmaBiz - Jul 08 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 2 reports

Court Report -- Part II - July 2014

About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases .Otsuka Pharmaceutical Co. Ltd. v. Par Pharmaceutical Inc.1:14-cv-00789; filed June 20, 2014 in the District Court of DelawareInfringement of U.S. Patent ... [Published JD Supra - Jul 07 2014]

Quotes

"Stability results found the product did not meet the drug release dissolution specifications" the FDA said in a post on its website on Friday
"They tend to have problems with their medication," said Schultz. "It’s possible that’s because it’s overprescribed, it’s also possible because the population itself is troubled and they have difficulty keeping things straight."
"The present invention relates to the preparation of substantially pure diastereoisomers of derivatives of tetrahydrofolate and the use of such diastereoisomers."
...But I don't think there's any way to read that sentence to mean "... and my guy paid that guy for his information."

More Content

All (718) | News (581) | Reports (0) | Blogs (130) | Audio/Video (0) | Fact Sheets (0) | Press Releases (7)
sort by: Date | Relevance
Healthy food, not comfort food, best for cancer... [Published Daily Local News - 41 mins ago]
Actavis plc confirms generic Diclegis patent ch... [Published Reuters UK - 44 mins ago]
Sun Pharma’s latest U.S. drug recall involves 4... [Published MedCity News - 6 hours ago]
New Rx, policies benefit women’s health [Published Drug Store News - 7 hours ago]
India's Sun Pharma recalls over 40,000 bottles ... [Published Yahoo! Finance - 11 hours ago]
Mylan to appeal EC anti-trust findings against ... [Published Hindu Business Line - 13 hours ago]
Pharmaceuticals Newsletter – July 07 to 11, 2014 [Published India Infoline - 16 hours ago]
Teva’s Generic Nasonex Bid Is Challenged by Merck [Published FDA News - Jul 10 2014]
Insurers balk at pricey generic version of anci... [Published FiercePharma - Jul 10 2014]
Indian stock market and companies daily report ... [Published Stock Markets Review - Jul 10 2014]
India : GLENMARK gets USFDA approval for Telmis... [Published Pharmacy Choice - Jul 10 2014]
Psychiatric drugs associated with 90,000 ER vis... [Published SCPR - Jul 10 2014]
Spectrum Pharmaceuticals: Key Drug Fusilev May ... [Published Seeking Alpha - Jul 09 2014]
Actavis and Forest Receive U.S. FTC Clearance f... [Published 4 Traders - Jul 09 2014]
EU slaps Rs 324-cr fine on Lupin for blocking h... [Published Business Standard India - Jul 09 2014]
Rengan Rajaratnam Case Shows Right Way to Insid... [Published Bloomberg View - Jul 09 2014]
EU fines pharma-giants €427mn in ‘pay for delay... [Published EUobserver - Jul 09 2014]
Lupin, Unichem intend to appeal EC findings [Published Hindu Business Line - Jul 09 2014]
Sandoz Launches Generic Diovan in the U.S. [Published Drug Discovery and Development - Jul 09 2014]
BP : Office of the National Coordinator for Hea... [Published 4 Traders - Jul 09 2014]
EU's third pay-for-delay action nails Servier, ... [Published FiercePharma - Jul 09 2014]
Wednesday’s Top Biotech Stories: Celgene, AbbVi... [Published Motley Fool - Jul 09 2014]
Acorda fights Actavis on generic of its multipl... [Published Pharma Letter - Jul 09 2014]
Glenmark receives USFDA approval for telmisarta... [Published Business Standard India - Jul 09 2014]
Mylan unveils the US FDA approved generic Micar... [Published Individual.com - Jul 09 2014]
EU fines French drug maker Servier [Published Trading Room - Jul 09 2014]
TEVA PHARMACEUTICAL : EU Fines Servier, Generic... [Published 4 Traders - Jul 09 2014]
EU hits French drugmaker Servier with huge fine... [Published News.net - Jul 09 2014]
AFP - EU-France-Israel-antitrust-pharma [Published Namibia Press Agency - Jul 09 2014]
Glenmark Pharmaceuticals gains as its arm recei... [Published Arihant Capital - Jul 09 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Mylan Launches Generic Micardis® Tablets [Published PR Newswire: General Business - Jul 08 2014]
PITTSBURGH, July 8, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Telmisartan Tablets USP, 20 mg, 40 mg and 80 mg, the generic version of Boehringer Ingelheim's Micardis® Tablets. Mylan received final approval from ...
Court Report -- Part II [Published Patent Docs - Jul 04 2014]
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Otsuka Pharmaceutical Co. Ltd. v. Par Pharmaceutical Inc. 1:14-cv-00789; filed June 20, 2014 in the District Court of Delaware Infringement ...
Did FDA Make the Wrong Call on Ranbaxy and Gene... [Published WSJ.com: India Real Time - Jun 30 2014]
For U.S. consumers, this may be a case of ‘better late, than never.’ After a two-year wait, Ranbaxy Laboratories finally received FDA approval to sell a generic version of the best-selling Diovan heart medicine. The decision means that Americans who take ...
Dr. Reddy’s Announces the Launch of Duloxetine ... [Published EON Science - Jun 27 2014]
HYDERABAD, India--(EON: Enhanced Online News)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Duloxetine Delayed-Release Capsules USP 20 mg, 30 mg and 60 mg, a therapeutic equivalent generic version of CYMBALTA® (Duloxetine ...
Dr. Reddy’s Announces the Launch of Duloxetine ... [Published Business Wire Science: Science News - Jun 27 2014]
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Duloxetine Delayed-Release Capsules USP 20 mg, 30 mg and 60 mg, a therapeutic equivalent generic version of CYMBALTA® (Duloxetine Delayed-Release ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Milan District Court Confirms the Validity of A... [Published Financial Services - Jun 12 2014]
ACETO Subsidiary Rising Pharmaceuticals Launche... [Published GlobeNewswire: Acquisitions News - Jun 11 2014]
CorePharma, LLC Announces the Launch of Dextroa... [Published Financial Services - Jun 04 2014]
ACETO Subsidiary, Rising Pharmaceuticals, Has L... [Published GlobeNewswire: Acquisitions News - May 27 2014]
Actavis Extends Exclusive Agreement to Distribu... [Published Financial Services - May 15 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.